Inactivation of BRCA1 and BRCA2 in Ovarian Cancer von Hilton, Jeffrey L., Geisler, John P., Rathe, Jennifer A., Hattermann-Zogg, Melanie A., DeYoung, Barry, Buller, Richard E.

Volltext

Neoadjuvant chemotherapy in vulvar cancer: Avoiding primary exenteration von Geisler, John P., Manahan, Kelly J., Buller, Richard E.

Volltext

Frequency of BRCA1 Dysfunction in Ovarian Cancer von Geisler, John P., Hatterman-Zogg, Melanie A., Rathe, Jennifer A., Buller, Richard E.

Volltext

Outcome of Reproductive Age Women with Stage IA or IC Invasive Epithelial Ovarian Cancer Treated with Fertility-Sparing Therapy von Schilder, Jeanne M, Thompson, Amy M, DePriest, Paul D, Ueland, Frederick R, Cibull, Michael L, Kryscio, Richard J, Modesitt, Susan C, Lu, Karen H, Geisler, John P, Higgins, Robert V, Magtibay, Paul M, Cohn, David E, Powell, Matthew A, Chu, Christina, Stehman, Frederick B, van Nagell, John

Volltext

Abstract OT3-07-04: A randomized study comparing MoistHer to topical lidocaine for female breast cancer survivors with dyspareunia von Bendinger, GM, Baptist, S, Alvarez Tapias, C, McGuire, E, Rados, K, Nixon, D, Randolph, K, McNight, JE, Pabbathi, H, Panicker, R, Johnson, AT, Geisler, JP, Manahan, KJ, Lammersfeld, C, Avarez, RH

Volltext

Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma von Geisler, John P., Goodheart, Michael J., Sood, Anil K., Holmes, Richard J., Hatterman‐Zogg, Melanie A., Buller, Richard E.

Volltext

Is the routine use of bevacizumab in the treatment of women with advanced or recurrent cancer of the cervix sustainable? von Klag, Natalie, Walter, Adam C, Sheely, Kristen M, Manahan, Kelly J, Geisler, John P

Volltext

What Staging Surgery Should Be Performed on Patients with Uterine Papillary Serous Carcinoma? von Geisler, John P., Geisler, Hans E., Melton, Marvin E., Wiemann, Michael C.

Volltext

p21 and p53 in ovarian carcinoma: Their combined staining is more valuable than either alone von GEISLER, Hans E, GEISLER, John P, MILLER, Greg A, GEISLER, Marcia J, WIEMANN, Michael C, ZHEN ZHOU, CRABTREE, William

Volltext

Radical Hysterectomy in the Elderly Female: A Comparison to Patients Age 50 or Younger von Geisler, John P., Geisler, Hans E.

Volltext

p53 Expression as a Prognostic Indicator of 5-Year Survival in Endometrial Cancer von Geisler, John P., Geisler, Hans E., Wiemann, Michael C., Zhou, Zhen, Miller, Greg A., Crabtree, William

Volltext

Brain Metastases in Epithelial Ovarian Carcinoma von Geisler, John P., Geisler, Hans E.

Volltext

Failure of BRCA1 Dysfunction to Alter Ovarian Cancer Survival von BULLER, Richard E, SHAHIN, Mark S, GEISLER, John P, ZOGG, Melanie, DE YOUNG, Barry R, DAVIS, Charles S

Volltext

MIB-1 in Endometrial Carcinoma: Prognostic Significance with 5-Year Follow-Up von Geisler, John P., Geisler, Hans E., Miller, Greg A., Wiemann, Michael C., Zhou, Zhen, Crabtree, William

Volltext

Nuclear and cytoplasmic c‐myc staining in endometrial carcinoma and their relationship to survival von Geisler, J. P., Geisler, H. E., Manahan, K. J., Miller, G. A., Wiemann, M. C., Zhou, Z., Crabtree, W.

Volltext

Gemcitabine associated vasculitis leading to necrotizing enterocolitis and death in women undergoing primary treatment for epithelial ovarian/peritoneal cancer von Geisler, John P, Schraith, Daniel F, Manahan, Kelly J, Sorosky, Joel I

Volltext

A Study of Heat Shock Protein 27 in Endometrial Carcinoma von Geisler, John P., Geisler, Hans E., Tammela, Jonathon, Miller, Greg A., Wiemann, Michael C., Zhou, Zhen

Volltext

p53 and bcl-2 in Epithelial Ovarian Carcinoma: Their Value as Prognostic Indicators at a Median Follow-up of 60 Months von Geisler, John P., Geisler, Hans E., Miller, Greg A., Wiemann, Michael C., Zhou, Zhen, Crabtree, William

Volltext

Papillary Serous Carcinoma of the Uterus: Increased Risk of Subsequent or Concurrent Development of Breast Carcinoma von Geisler, John P., Sorosky, Joel I., Duong, Hai-Lang, Buekers, Thomas E., Geisler, Marcia J., Sood, Anil K., Anderson, Barrie, Buller, Richard E.

Volltext

Sequential intraperitoneal topotecan and oral etoposide chemotherapy in recurrent platinum-resistant ovarian carcinoma: Results of a phase II trial von SOOD, Anil K, LUSH, Richard, GEISLER, John P, SHAHIN, Mark S, SANDERS, Linda, SULLIVAN, Dan, BULLER, Richard E, SOROSKY, Joel I

Volltext